Skip to main content
Clinical Trials/NCT05812599
NCT05812599CompletedNot Applicable

Rapid Acceleration of Diagnostics Underserved Populations Supplement: Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

Washington University School of Medicine1 site in 1 country298 target enrollmentStarted: September 22, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
298
Locations
1
Primary Endpoint
Proportion of participants who answer post-test questions correctly

Study Overview

Brief Summary

The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Previous study findings and evidence-based health communication and education tactics were integrated to create an interactive learning module that includes four narrative scenarios, illustrations, and accompanying questions and responses that inform the audience about COVID testing guidelines. The study will test the effectiveness of the interactive learning module with 2-1-1 callers (n=300) in Connecticut, North Carolina, and Nebraska. Participants' contact information will be shared with us by 2-1-1 with the participants' given consent. The study team will send the potential participant via text message a link to a survey that includes a screen where they will provide informed consent. Those who provide consent will be randomly assigned to receive one of two surveys. The inclusion of the interactive learning module is what varies across the surveys. An experimental group will receive the learning module with a study team-developed pre- and post-survey, and the control group will receive only the study team-developed pre- and post-survey. The post-survey contains questions regarding information covered in the interactive learning module. It is hypothesized that those who complete the interactive learning module in the experimental group will score better on the post-survey questions when compared to the control group. All participants, regardless of experimental or control condition, will receive an information sheet with the most up-to-date scientific guidelines for COVID testing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Individuals who called 211 in Connecticut, Nebraska, or North Carolina on behalf of themselves or their families
  • •Must be 18 or older
  • •Must have English language proficiency
  • •Must be willing to be contacted via text messages or email

Exclusion Criteria

  • Not provided

Arms & Interventions

COVID Test Learning Module

Experimental

In the experimental condition, participants will respond to survey questions (pre-exposure) before being presented with four narrative scenarios, questions, and accompanying messages about COVID testing (exposure), followed by post-test survey questions about COVID testing behaviors (post-exposure).

Intervention: Educational Module (Other)

Control

No Intervention

In the control condition, participants will respond to survey questions (pre-exposure) and post-test survey questions about COVID testing behaviors (post-exposure) only.

Outcomes

Primary Outcomes

Proportion of participants who answer post-test questions correctly

Time Frame: Through survey completion, an average of 10-15 minutes.

The primary objective of this study is to evaluate differences in knowledge regarding COVID testing between 2-1-1 callers randomized to the control vs. experimental group. Participants who do better would answer more items correctly on the COVID prevention knowledge post-test. Assessed using a non-parametric t-test.

Secondary Outcomes

  • Number of participants with knowledge gained after exposure to learning module(Through survey completion, an average of 10-15 minutes.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Matthew Kreuter

Principal Investigator

Washington University School of Medicine

Study Sites (1)

Loading locations...

Similar Trials